日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Post-Chemotherapy Changes and Agreement of CT-Derived Body Composition at L3 and T12 in Older Patients with Metastatic Colorectal Cancer: Associations with Nutritional Indices and Outcomes

老年转移性结直肠癌患者化疗后L3和T12节段CT衍生身体成分的变化及一致性:与营养指标和预后的关联

Yıldız, Anıl; Ahmed, Melin Aydan; Eren, Nihan Nizam; Azizy, Abdulmunir; Artan, Selay; Çokgezer, Simay; Ulufer, Bedirhan; Aygörmez, Ozan Deniz; Karaoğlan, Gündüz; Tırnova, Şirin Zelal Şahin; Bahat, Gulistan; Durmaz, Mustafa; Yırgın, İnci Kızıldağ; Karabulut, Senem; Sakar, Burak; Karan, Mehmet Akif; Taştekin, Didem

Prognostic Role of Endocan and Platelet-Derived Growth Factor Isoforms in Metastatic Colorectal Cancer.

内皮素和血小板衍生生长因子同工型在转移性结直肠癌中的预后作用。

Yıldız Anıl, Ahmed Melin Aydan, Azizy Abdulmunir, Çokgezer Simay, Ulufer Bedirhan, Soydinç Hilal Oğuz, Karabulut Sanem, Taştekin Didem, Şakar Burak, Ak Naziye

Prognostic Significance of Nomogram and T-Score in Locally Advanced Cervical Cancer Patients Treated with Curative Chemoradiotherapy and Image-Guided Brachytherapy: A Single-Center Retrospective Study

列线图和T评分在接受根治性放化疗和影像引导近距离放射治疗的局部晚期宫颈癌患者中的预后意义:一项单中心回顾性研究

Ibis, Kamuran; Ilgin, Can; Suncak, Leyla; Akbas, Canan Koksal; Bolukbas, Deniz; Denizli, Mustafa; Azizy, Abdulmunir; Yilmaz, Begum; Ozben, Seda Guler; Celik, Ayca Iribas; Kucucuk, Nezihe Seden; Yirgin, Inci Kizildag

Rechallenge of trastuzumab-based therapy in HER2-positive breast cancer patients who progressed after lapatinib plus capecitabine

对于接受拉帕替尼联合卡培他滨治疗后病情进展的HER2阳性乳腺癌患者,可考虑再次使用曲妥珠单抗治疗。

Khanmammadov, Nijat; Doğan, Izzet; Khishigsuren, Bayarmaa; Azizy, Abdulmunir; Saip, Pinar; Aydiner, Adnan

Comparative analysis of doublet chemotherapy regimens plus bevacizumab in patients with recurrent ovarian cancer

对复发性卵巢癌患者采用双药化疗方案联合贝伐单抗的疗效进行比较分析

Khanmammadov, Ni Jat; Doğan, İzzet; Okay, Necla Simay; Azizy, Abdulmunir; Saip, Pinar; Aydiner, Adnan

Comparison of efficacy and safety of 5-FU or capecitabine combined with cisplatin and docetaxel (mDCF and mDCX) as a first-line chemotherapy regimen in her 2-negative metastatic gastric cancer patients: A retrospective study

比较5-氟尿嘧啶或卡培他滨联合顺铂和多西他赛(mDCF和mDCX)作为Her 2阴性转移性胃癌患者一线化疗方案的疗效和安全性:一项回顾性研究

Demirci, Nebi Serkan; Azizy, Abdulmunir; Paksoy, Nail; Doğan, İzzet; Karabulut, Senem; Karahan, Latif; Tastekin, Didem

Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group

卡培他滨联合替莫唑胺方案治疗神经内分泌肿瘤的疗效:来自土耳其肿瘤协作组的数据

Ünal, Çağlar; Azizy, Abdulmunir; Karabulut, Senem; Taştekin, Didem; Akyıldız, Arif; Yaşar, Serkan; Yalçın, Şuayib; Çoban, Eyüp; Evrensel, Türkkan; Kalkan, Ziya; Oruç, Zeynep; Derin, Sümeyra; Turna, Zeynep Hande; Bayram, Doğan; Köş, Fahriye Tuğba; Şendur, Mehmet Ali Nihat; Sever, Nadiye; Ercelep, Özlem; Seyyar, Mustafa; Kefeli, Umut; Uygun, Kazım; Özçelik, Melike; Ön, Sercan; Şanlı, Ulus Ali; Canaslan, Kübra; Ünek, İlkay Tuba; Yücel, Kadriye Bir; Özdemir, Nuriye; Yazıcı, Ozan; Güzel, Halil Göksel; Salim, Derya Kıvrak; Göksu, Sema Sezgin; Tatlı, Ali Murat; Ordu, Çetin; Selvi, Oğuzhan; Sakin, Abdullah; Büyükbayram, Mehmet Emin; Dursun, Bengü; Ürün, Yüksel; Arak, Hacı; Ağdaş, Gözde; Uğraklı, Muzaffer; Hendem, Engin; Eryılmaz, Melek Karakurt; Bilgin, Burak; Topçu, Atakan; Şimşek, Melih; Büyükşimşek, Mahmut; Akay, Büşra; Erdal, Gülçin Şahingöz; Karataş, Fatih; Alan, Özkan; Çağlayan, Melek; Kahvecioğlu, Fatma Akdağ; Demirci, Ayşe; Paksoy, Nail; Çetin, Bülent; Gümüş, Mahmut; Ak, Naziye; Aydınalp, Yasemin; Paydaş, Semra; Güven, Deniz Can; Kılıçkap, Saadettin; Sağlam, Sezer

Immunohistochemical expression of plasminogen activator inhibitor-1 in subcutaneous versus omental adipose tissue in patients after elective abdominal surgery

择期腹部手术后患者皮下脂肪组织与大网膜脂肪组织中纤溶酶原激活物抑制剂-1的免疫组织化学表达

Yildiz, Mehmet; Bozkurtlar, Emine; Azizy, Abdulmunir; Agirbasli, Mehmet